Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 12:37 pm Purchase |
2022-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
CHI Advisors LLC | 3,199,892 6.560% |
630,413 (+24.53%) |
Filing History |
| 2023-02-13 12:36 pm Purchase |
2022-12-31 | 13G | Oncorus, Inc. ONCR |
CHI Advisors LLC | 2,367,436 9.110% |
260,533 (+12.37%) |
Filing History |
| 2023-02-13 12:36 pm Purchase |
2022-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
CHI Advisors LLC | 3,317,544 7.250% |
840,824 (+33.95%) |
Filing History |
| 2023-02-13 12:09 pm Purchase |
2022-12-31 | 13G | Inozyme Pharma, Inc. INZY |
CHI Advisors LLC | 2,204,876 5.460% |
2,204,876 (New Position) |
Filing History |
| 2023-02-13 12:08 pm Purchase |
2022-12-31 | 13G | VectivBio Holding AG VECT |
CHI Advisors LLC | 5,492,893 8.760% |
2,817,485 (+105.31%) |
Filing History |
| 2023-02-13 12:07 pm Purchase |
2022-12-31 | 13G | Repare Therapeutics Inc. RPTX |
CHI Advisors LLC | 2,800,126 6.670% |
587,870 (+26.57%) |
Filing History |
| 2023-02-13 12:06 pm Purchase |
2022-12-31 | 13G | Orchard Therapeutics plc ORTX |
CHI Advisors LLC | 798,740 6.300% |
153,754 (+23.84%) |
Filing History |
| 2023-02-13 12:04 pm Purchase |
2022-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
CHI Advisors LLC | 3,473,366 8.030% |
1,958,218 (+129.24%) |
Filing History |
| 2023-02-13 12:01 pm Purchase |
2022-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
CHI Advisors LLC | 320,961 7.410% |
195,869 (+156.58%) |
Filing History |
| 2023-02-13 12:01 pm Purchase |
2022-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
CHI Advisors LLC | 2,384,402 5.120% |
2,384,402 (New Position) |
Filing History |
| 2022-02-11 1:51 pm Purchase |
2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
CHI Advisors LLC | 2,569,479 7.130% |
214,680 (+9.12%) |
Filing History |
| 2022-02-11 1:51 pm Purchase |
2021-12-31 | 13G | Oncorus, Inc. ONCR |
CHI Advisors LLC | 2,106,903 8.160% |
426,997 (+25.42%) |
Filing History |
| 2022-02-11 1:39 pm Purchase |
2021-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
CHI Advisors LLC | 2,476,720 5.670% |
2,476,720 (New Position) |
Filing History |
| 2022-02-11 1:01 pm Purchase |
2021-12-31 | 13G | Orchard Therapeutics plc ORTX |
CHI Advisors LLC | 644,986 5.140% |
644,986 (New Position) |
Filing History |
| 2022-02-11 1:00 pm Purchase |
2021-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
CHI Advisors LLC | 125,093 5.240% |
125,093 (New Position) |
Filing History |
| 2022-02-11 12:59 pm Purchase |
2021-12-31 | 13G | VectivBio Holding AG VECT |
CHI Advisors LLC | 2,675,408 7.610% |
2,675,408 (New Position) |
Filing History |
| 2022-02-11 11:36 am Sale |
2021-12-31 | 13G | Repare Therapeutics Inc. RPTX |
CHI Advisors LLC | 2,212,256 5.300% |
-319,894 (-12.63%) |
Filing History |
| 2022-02-11 11:34 am Unchanged |
2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
CHI Advisors LLC | 1,515,148 8.560% |
0 (Unchanged) |
Filing History |
| 2021-03-02 3:41 pm Purchase |
2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
CHI Advisors LLC | 2,354,799 6.600% |
2,354,799 (New Position) |
Filing History |
| 2021-03-02 3:37 pm Purchase |
2020-12-31 | 13G | Oncorus, Inc. ONCR |
CHI Advisors LLC | 1,679,906 6.600% |
1,679,906 (New Position) |
Filing History |